Non-Vascular Stents Market is expected to be appraised at US$ 1.9 Bn by 2032

 The Non-Vascular Stents Market is expected to grow at a CAGR of 4.5% over the forecast period. (2022 - 2032). The sector is expected to be valued at US$ 1.21 billion in 2022 and US$ 1.9 billion by 2032.

The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth.

Get Full Access @ https://www.futuremarketinsights.com/reports/non-vascular-stents-market

Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy.

The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years.

Such a surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, encouraging many to opt for the same.

Furthermore, patients are less likely to contract hospital-acquired illnesses like bloodstream infections and urinary tract infections if they stay in the hospital for a shorter period of time, in turn, propelling the demand for non-vascular stents.

The most visible and prominent factor spiking the sales of non-vascular stents is a surge in cases of chronic obstructive pulmonary disease (COPD), which is caused by smoking, lung cancer, tracheobronchial malacia, and chemical exposure.

Key Takeaways:

• Based on product type, the urological stents segment is likely to dominate the non-vascular stents market with a CAGR of 4.3% through 2032.
• The US non-vascular stents market is expected to capture a sizeable non-vascular stents market share accounting for around US$659.1 million by 2032.
• By 2032, the UK non-vascular stents market is expected to be valued at US$ 80.6 million, growing at a CAGR of 3.3%.
• With a CAGR of 3.6% during the forecast period, China non-vascular stents market size is predicted to be apprised at US$ 128.1 million by 2032.  
• The Japan non-vascular stents market, with a CAGR of 3.9%, is projected to garner a worth of US$ 109.8 million by 2032.

Competitive Landscape:

·         Some of the leading non-vascular stents companies include Medtronic plc, Glaukos Corporation, Boston Scientific Corporation, ELLA - CS, s.r.o., CONMED Corporation.

·         One of the recent developments in the non-vascular stents market is when Medtronic acquired Medicrea, a fully dedicated spinal implant company focused on bringing reliable and cutting-edge technology to the global market.